MFDS — authorised 18 March 2022
- Marketing authorisation holder: MARINUS PHARMA INC
- Status: likely_approved
🇰🇷 Ztalmy in South Korea
MFDS authorised Ztalmy on 18 March 2022
Marketing authorisation
Ztalmy in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Ztalmy approved in South Korea?
Yes. MFDS authorised it on 18 March 2022.
Who is the marketing authorisation holder for Ztalmy in South Korea?
MARINUS PHARMA INC holds the South Korean marketing authorisation.